Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity

被引:253
作者
Fritz, Jorg H.
Le Bourhis, Lionel
Sellge, Gernot
Magalhaes, Joao Gamelas
Fsihi, Hafida
Kufer, Thomas A.
Collins, Cathy
Viala, Jerome
Ferrero, Richard L.
Girardin, Stephen E.
Philpott, Dana J.
机构
[1] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[4] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France
[5] INSERM, U786, F-75724 Paris 15, France
[6] Inst Pasteur, Unite Rech Mycol Mol, F-75724 Paris 15, France
[7] Hop Robert Debre, AP HP, Dept Paediat Gastroenterol & Nutr, F-75935 Paris 19, France
[8] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia
基金
加拿大健康研究院; 奥地利科学基金会; 英国医学研究理事会;
关键词
D O I
10.1016/j.immuni.2007.03.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent evidence has suggested that signals other than those from Toll-like receptors (TLRs) could contribute to the elicitation of antigen-specific immunity. Therefore, we examined the role of the Nod-like receptor (NLR) family member, Nod1, in the generation of adaptive immune responses. Our findings show that innate immune sensing of peptidoglycan by Nod1 is key for priming antigen-specific T cell immunity and subsequent antibody responses in vivo. Nod1 stimulation alone was sufficient to drive antigen-specific immunity with a predominant Th2 polarization profile. In conjunction with TLR stimulation, however, Nod1 triggering was required to instruct the onset of Th1 and Th2 as well as Th17 immune pathways. Cells outside of the hematopoietic lineage provided the early signals necessary to orchestrate the development of Nod1-dependent immune responses. These findings highlight Nod1 as a key innate immune trigger in the local tissue microenvironment that drives the development of adaptive immunity.
引用
收藏
页码:445 / 459
页数:15
相关论文
共 55 条
  • [1] [Anonymous], J EXP MED, DOI DOI 10.1084/JEM
  • [2] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [3] Bacterial invasion: The paradigms of enteroinvasive pathogens
    Cossart, P
    Sansonetti, PJ
    [J]. SCIENCE, 2004, 304 (5668) : 242 - 248
  • [4] Toll-like receptors and T-helper-1/T-helper-2 responses
    Dabbagh, K
    Lewis, DB
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (03) : 199 - 204
  • [5] Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies
    Daly, C
    Rollins, BJ
    [J]. MICROCIRCULATION, 2003, 10 (3-4) : 247 - 257
  • [6] Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori
    Ferrero, RL
    [J]. MOLECULAR IMMUNOLOGY, 2005, 42 (08) : 879 - 885
  • [7] Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection
    Ferrero, RL
    Thiberge, JM
    Huerre, M
    Labigne, A
    [J]. INFECTION AND IMMUNITY, 1998, 66 (04) : 1349 - 1355
  • [8] NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis
    Ferwerda, Gerben
    Girardin, Stephen E.
    Kullberg, Bart-Jan
    Le Bourhis, Lionel
    de Jong, Dirk J.
    Langenberg, Dennis M. L.
    van Crevel, Reinout
    Adema, Gosse J.
    Ottenhoff, Tom H. M.
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    [J]. PLOS PATHOGENS, 2005, 1 (03) : 279 - 285
  • [9] Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists
    Fritz, JH
    Girardin, SE
    Fitting, C
    Werts, C
    Mengin-Lecreulx, D
    Caroff, M
    Cavaillon, JM
    Philpott, DJ
    Adib-Conquy, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (08) : 2459 - 2470
  • [10] The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens
    Fritz, JH
    Brunner, S
    Birnstiel, ML
    Buschle, M
    Gabain, AV
    Mattner, F
    Zauner, W
    [J]. VACCINE, 2004, 22 (25-26) : 3274 - 3284